| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/28/2008 | US20080050314 Diagnostics and Therapeutics for Diseases Associated With Glycogen Synthase Kinase 3 Beta (Gsk3b) |
| 02/28/2008 | US20080050313 Sulfs as Modifiers of the Beta-Catenin Pathway and Methods of Use |
| 02/28/2008 | US20080050310 Antibodies and immunoconjugates and uses therefor |
| 02/28/2008 | CA2662862A1 Treatment of aplastic anemia |
| 02/28/2008 | CA2661924A1 Treatment of graft-versus-host disease |
| 02/28/2008 | CA2661814A1 Recombinant hcv e2 glycoprotein |
| 02/28/2008 | CA2661669A1 A pharmaceutical composition for treating cholangiocarcinoma, a method for inhibiting growth or invasion of cholangiocarcinoma and a method for treating cholangniocarcinoma |
| 02/28/2008 | CA2661665A1 A pharmaceutical composition for treating lung cancer, a method for inhibiting growth or invasion of lung cancer and a method for treating lung cancer |
| 02/28/2008 | CA2661492A1 Hcv fusion polypeptides |
| 02/28/2008 | CA2661468A1 Tissue culture system for production of hepatitis c virus |
| 02/28/2008 | CA2660681A1 Tumor therapy with an anti-vegf antibody |
| 02/28/2008 | CA2660156A1 Anti-c5ar antibodies with improved properties |
| 02/28/2008 | CA2658000A1 Use of cd83 in combination therapies |
| 02/27/2008 | EP1892298A1 Streptococcal C5a peptidase vaccine |
| 02/27/2008 | EP1892297A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
| 02/27/2008 | EP1892251A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 02/27/2008 | EP1891972A1 Agent for promoting hepatic cell replication and agent for improving insulin resistance |
| 02/27/2008 | EP1891970A1 Beta glucan-based vaccines free of mannoprotein |
| 02/27/2008 | EP1891969A2 Novel anti-allergic agents |
| 02/27/2008 | EP1891968A2 Rotavirus vaccine formulations |
| 02/27/2008 | EP1891966A1 Modulation of activity of neurotrophins |
| 02/27/2008 | EP1891965A1 Hip-Kinase for fertility controll |
| 02/27/2008 | EP1891445A2 Method for diagnosing neurodegenerative disease |
| 02/27/2008 | EP1891236A2 Diagnostic and therapeutic target cdc2l6 proteins for neurodegenerative diseases |
| 02/27/2008 | EP1891210A1 Dengue serotype 2 attenuated strain |
| 02/27/2008 | EP1891115A2 Anti her2/neu antibody |
| 02/27/2008 | EP1891114A2 Anti-trkb monoclonal antibodies and uses thereof |
| 02/27/2008 | EP1891110A2 STABLE AND SOLUBLE ANTIBODIES INHIBITING TNF-alpha |
| 02/27/2008 | EP1891109A1 Cardiovascular disease therapies |
| 02/27/2008 | EP1891096A2 Immunogenic compositions for chlamydia trachomatis |
| 02/27/2008 | EP1891095A2 Immunoreactive protein orthologs of ehrlichia canis and e. chaffeensis |
| 02/27/2008 | EP1890726A1 Novel analgesic treatment with prolonged effect |
| 02/27/2008 | EP1890725A2 Vaccine compositions and methods for the treatment of urinary incontinence |
| 02/27/2008 | EP1890724A2 Compositions for inducing an immune response |
| 02/27/2008 | EP1507560B1 Immune stimulating and controlling composition comprising bacterial chromosomal dna fragments and non-toxic lipopolysaccharides |
| 02/27/2008 | EP1334731B1 Preventives or remedies for psoriasis containing as the active ingredient il-6 antagonist |
| 02/27/2008 | EP1282700B1 Neuronal serine-threonine protein kinase |
| 02/27/2008 | EP1163000B1 Vaccine against antigens from bacteriae |
| 02/27/2008 | EP1137758B1 Method and composition for preserving adenoviruses |
| 02/27/2008 | EP1102850B1 Regions of papilloma virus e1 helicase involved in e1 oligomerization |
| 02/27/2008 | EP0942968B1 Fully human antibodies that bind EGFR |
| 02/27/2008 | EP0739350B1 Ligand that binds fas antigen |
| 02/27/2008 | CN101133163A Isolated chimeric proteins of modified lumazine synthase |
| 02/27/2008 | CN101133158A 人抗狂犬病抗体及其用途 Human anti-rabies antibodies and their use |
| 02/27/2008 | CN101133083A 人源化的抗cd47抗体 Humanized anti-cd47 antibody |
| 02/27/2008 | CN101132811A High affinity antibodies against HMGB1 and methods of use thereof |
| 02/27/2008 | CN101132810A Glycoconjugate vaccines containing peptidoglycan |
| 02/27/2008 | CN101132773A Pharmaceutical composition |
| 02/27/2008 | CN101132694A Medical device with coating for capturing genetically-altered cells and methods of using same |
| 02/27/2008 | CN101130780A Process for preparing A type hoof-and-mouth disease subunit vaccine |
| 02/27/2008 | CN101130090A Application of BRSK2 in producing antidiabetic medicine |
| 02/27/2008 | CN101130079A Application of lactoferrin in preparing medicament for preventing and controlling disease caused by human rotavirus |
| 02/27/2008 | CN101130078A Intrathecal administration of rituximab for treatment of central nervous system lymphomas |
| 02/27/2008 | CN101130077A Remedy for spinal injury containing interleukin-6 antagonist |
| 02/27/2008 | CN101130076A Method of preparing polyvalent vaccine of viable bacteria |
| 02/27/2008 | CN101130075A Tervalence inactivated vaccine for type O, A, Asia-1 hoof-and-mouth disease |
| 02/27/2008 | CN101130074A Medicament for treating and/or preventing hepatitis B |
| 02/27/2008 | CN101130073A Protein expression in baculovirus vector expression systems |
| 02/27/2008 | CN101130072A Type A inactivated vaccine for hoof-and-mouth disease |
| 02/27/2008 | CN101130071A Vaccine |
| 02/27/2008 | CN101130070A Vaccine against sexually transmitted diseases |
| 02/27/2008 | CN101129327A Micro-projection array having a beneficial agent containing coating |
| 02/27/2008 | CN100371348C Treatment of micro-organism infection |
| 02/27/2008 | CN100371022C Method for establishing anti-hepatitis C virus drug screening experimental animal model |
| 02/26/2008 | US7335759 Recombinant immunogens for the generation of antivenoms to the venom of scorpions of the genus Centruroides |
| 02/26/2008 | US7335754 Ehrlichia canis genes and vaccines |
| 02/26/2008 | US7335748 RG1 antibodies and uses thereof |
| 02/26/2008 | US7335744 Prostate cancer specific internalizing human antibodies |
| 02/26/2008 | US7335743 Immunoglobulin for use in treatment and prevention of viral infection, glandular, inflammatory, nervous system, blood, skin, cardiovascular and liver disorders; immunotherapy |
| 02/26/2008 | US7335736 Compositions and methods for detecting Treponema palidum |
| 02/26/2008 | US7335733 Tissue cement proteins from Rhipicephalus appendiculatus |
| 02/26/2008 | US7335681 Inhibit glucosyl ceramide (GlcCer) formation by inhibiting the enzyme GlcCer synthase; Gaucher's disease, Tay Sachs disease, Fabry's disease. Sandhoff disease or GM1 gangliosidosis |
| 02/26/2008 | US7335649 3-{N'-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2-hydroxy-3'-(tetrazol-5-yl)biphenyl for treatment of thrombocytopenia; colony stimulating factors |
| 02/26/2008 | US7335640 Using hypocretin receptor agonist; sleep disorders |
| 02/26/2008 | US7335637 Biglycan and related therapeutics and methods of use |
| 02/26/2008 | US7335636 SPRR1A and axonal regeneration |
| 02/26/2008 | US7335516 Methods to improve immunogenicity of antigens and specificity of antibodies |
| 02/26/2008 | US7335499 tRNA synthetase |
| 02/26/2008 | US7335494 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 02/26/2008 | US7335493 nucleic acids capable of binding mRNA from Streptococcus. pneumoniae proteins to block protein translation; a cell containing the recombinant expression vector of such nucleic acid operably linked to a transcription regulatory element |
| 02/26/2008 | US7335482 Method using neutral amino acid transporter expressing cell |
| 02/26/2008 | US7335480 Enriched antibody for detecting mycobacterial infection, methods of use and diagnostic test employing same |
| 02/26/2008 | US7335477 Truncated recombinant major outer membrane protein antigen (r56) of Orientia tsutsugamushi strains Karp, Kato and Gilliam and its use in antibody based detection assays and vaccines |
| 02/26/2008 | US7335473 Causative agent of the Mystery Swine Disease, vaccine compositions and diagnostic kits |
| 02/26/2008 | US7335468 Isolated protein complexes; screening analyzing; human t-cell leukemia virus |
| 02/26/2008 | US7335370 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 02/26/2008 | US7335369 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 02/26/2008 | US7335368 BVH-A2 and BVH-A3 antigens of group B Streptococcus |
| 02/26/2008 | US7335367 Reducing secretions from the meibomian glands; vision defects |
| 02/26/2008 | US7335366 Attenuated bovine respiratory syncytial virus |
| 02/26/2008 | US7335365 HIV-encoded chemoattractant |
| 02/26/2008 | US7335364 Modified Vaccinia Ankara virus variant |
| 02/26/2008 | US7335363 Membrane virus host range mutations and their uses as vaccine substrates |
| 02/26/2008 | US7335362 Methods of treating pre-eclampsia or eclampsia |
| 02/26/2008 | US7335361 Fusion antigen used as vaccine |
| 02/26/2008 | US7335360 Method and device for detecting feline immunodeficiency virus |
| 02/26/2008 | US7335359 Glycosylated specificity exchangers |
| 02/26/2008 | US7335358 Methods of treating psoriasis with anti-TNF antibodies |
| 02/26/2008 | US7335357 Antagonists of neuropilin receptor function and use thereof |
| 02/26/2008 | US7335356 Comprises two heavy chains and two light chains, each chain comprising a variable region and a constant region; vaccines for prevention and diagnosis of viral diseases |